LEANNE KNOWLES: Open Payments
NPI 1447635305 · VALLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 30 payments from 15 companies in 2025. Trend: 2023 $464 · 2024 $245 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| TerSera Therapeutics LLC | 3 | $59 |
| SOBI, INC | 2 | $45 |
| JAZZ PHARMACEUTICALS INC. | 2 | $44 |
| Incyte Corporation | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Adaptive Biotechnologies Corporation | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| ABBVIE INC. | 1 | $26 |
Products named: KISQALI, LIBTAYO, Zoladex, Vonjo, ZEPZELCA, PLUVICTO, Enhertu, clonoSEQ.
Industry payments across AL — which companies pay providers there.
